Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 1;68(Pt 7):o2249.
doi: 10.1107/S1600536812028115. Epub 2012 Jun 30.

2-(4-Bromo-phen-yl)-N-[3-(1H-imidazol-1-yl)prop-yl]quinazolin-4-amine

2-(4-Bromo-phen-yl)-N-[3-(1H-imidazol-1-yl)prop-yl]quinazolin-4-amine

Marcia Pérez-Fehrmann et al. Acta Crystallogr Sect E Struct Rep Online. .

Abstract

In the title compound, C(20)H(18)BrN(5), the bromo-phenyl-substituted quinazoline unit is essentially planar [maximum deviation = 0.098 (3) Å] and makes a dihedral angle of 56.04 (14)° with the imidazole ring. In the crystal, mol-ecules are associated by pairs of N-H⋯N hydrogen bonds to form inversion dimers. All the quinazoline planar systems are oriented almost perpendicular to the [110] direction, making π-π inter-actions possible between adjacent dimers [centroid-centroid distances = 3.7674 (16) and 3.7612 (17) Å]. There are also a number of C-H⋯π inter-actions present. The crystal is a nonmerohedral twin, with a minor twin fraction of 0.47.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
A view of the molecular structure of the title molecule with the atom numbering. The displacement ellipsoids are drawn at the 50% probability level.
Fig. 2.
Fig. 2.
A partial view perpendicular to (110) of the crystal packing of the title compound, showing the N-H···N hydrogen bonded (blue dashed lines; Table 1) inversion dimers and the overlap of the inversion related bromophenyl substituted quinazoline units.
Fig. 3.
Fig. 3.
A view along the c axis of the crystal packing of the title compound. Hydrogen bonds are shown as blue dashed lines (see Table 1 for details).

References

    1. Agilent (2010). CrysAlis PRO Agilent Technologies, Yarnton, Oxfordshire, England.
    1. Aguilar, L., Gimenez, M. J., García-Rey, C. & Martin, J. E. (2002). Antimicrob. Chemother. 50 (Suppl. C), 93–100. - PubMed
    1. Asproni, B., Murineddu, G., Pau, A., Pinna, G. A., Langgård, M., Christoffersen, C. T., Nielsen, J. & Kehler, J. (2011). Bioorg. Med. Chem. 19, 642–649. - PubMed
    1. Connolly, D. J., Cusack, D. O., Sullivan, T. P. & Guiry, P. J. (2005). Tetrahedron, 61, 10153–10202.
    1. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst. 42, 339–341.